RE:Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100If Capre results in lower LDL as well then there is no reason for ACST to be valued less than Amarin. There is still 6-7 months to go till results are out so expect the usual sp manipulation. Remember Acasti's market current market cap is about US$70 Million compared to Amarin's almost US$6 Billions....